

















Examination of toxoplasmosis in pregnant women
石山　聡子　　足髙　善彦
Satoko ISHIYAMA and Yoshihiko ASHITAKA
SUMMARY
  About 85～90％ of pregnant women have no antibodies against Toxoplasma gondii in Japan. Primary T. gondii 
infection is asymptomatic in most patients including pregnant women. Absence of anti－Toxoplasma IgG 
antibody in pregnant women may result into congenital toxoplasmosis in the fetuses provided the infection 
which is acquired during pregnancy. The prevalence is supported to be 0.05％ of live births. The various 
abnormalities include mental retardation, seizures, blindness, deafness and stillbirth including abortion. 
Therefore, it is important to know the time of infection acquired. Serologic tests are used to diagnose primary 
infection in pregnant women. IgG antibody arise within 1－2 weeks after infection and persist lifelong. 
Detection of Toxoplasma specific IgM antibody indicates recent infection, however, the exact time can not be 
determined. Measurement of IgG avidity has been used to distinguish the recent infection from the past one. 
Generally, during pregnancy, it is important to avoid eating raw or undercooked meat, avoid travels abroad 
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